XML 24 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Aug. 02, 2014
Aug. 03, 2013
Operating activities:    
Net income $ 37,862 $ 56,561
Adjustments to reconcile net income to net cash provided by/(used for) operating activities:    
Deferred income taxes (4,235) 13,456
Depreciation and amortization 55,927 51,667
Loss on disposal and write-down of property and equipment 604 1,754
Stock-based compensation 6,804 7,616
Non-cash interest and other non-cash items (786) (623)
Tax benefit from exercise/vesting of stock awards 1,072 1,480
Changes in assets and liabilities:    
Accounts receivable (2,896) (6,625)
Merchandise inventories (15,536) (30,421)
Prepaid expenses and other current assets (356) (816)
Refundable income taxes 594 930
Other non-current assets 623 (1,165)
Other non-current liabilities (3,543) 7,819
Accounts payable, accrued expenses and other current liabilities (27,432) (46,534)
Net cash provided by/(used for) operating activities 48,702 55,099
Investing activities:    
Purchases of marketable securities (1,808) (2,565)
Sales of marketable securities 1,162 574
Purchases of property and equipment (56,607) (60,679)
Other, net (250) 813
Net cash used for investing activities (57,503) (61,857)
Financing activities:    
Proceeds from the issuance of common stock pursuant to the Associate Discount Stock Purchase Plan 1,158 1,169
Proceeds from exercise of stock options 13,217 3,603
Excess tax benefits from stock-based compensation 1,696 1,676
Repurchases of common and restricted stock (54,556) (53,832)
Repayments of fixed asset financing and capital lease obligations (1,746) (751)
Change in trade payable program obligation, net (2,226) (4,988)
Net cash provided by/(used for) financing activities (42,457) (53,123)
Effect of exchange rate on cash and cash equivalents (124) (109)
Net increase/(decrease) in cash and cash equivalents (51,382) (59,990)
Cash and cash equivalents, beginning of period 201,707 167,011
Cash and cash equivalents, end of period $ 150,325 $ 107,021